EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frank, G.
Right arrow Articles by Borst, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frank, G.
Right arrow Articles by Borst, H. G.

European Journal of Cardio-Thoracic Surgery, Vol 2, 207-216, Copyright © 1988 by European Association for Cardio-thoracic Surgery


ARTICLES

Surgical alternatives in the treatment of life-threatening ventricular arrhythmias

G Frank, D Lowes, D Baumgart, A Haverich, H Klein, HJ Trappe, C Abraham and HG Borst
Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Federal Republic of Germany.

We present our experience in the treatment of life-threatening ventricular tachycardia using electrophysiologically guided surgery (97 patients), automatic implantable cardioverter defibrillator (AICD) (42 patients), and orthotopic heart transplantation (15 patients). Eighty- three percent of these patients had ischemic and 17%, nonischemic heart disease. Our results of electrophysiologically directed surgery show an early mortality of 10% and a recurrence of 5% in the ischemic group. In the nonischemic group, the recurrence was 45%. The AICD was implanted in 31 patients with ischemic heart disease, in 5 with ventricular dysplasia, and in 6 with dilative cardiomyopathy, the ejection fractions ranging from 12% to 65%, with a mean of 30%. Early and late mortalities were 5% and 19%, respectively. The AICD was effective in all patients. Survival rate at 1 year was 83% +/- 6.4%. Thirteen of 15 patients have survived heart transplantation for 3-20 months (mean: 11 months). Ejection fractions prior to transplantation ranged from less than 10% to 34% (mean: 16%). We conclude that electrophysiologically guided surgery is highly effective in most cases of ischemia-related ventricular tachycardia. The AICD is considered a palliative alternative in patients with either poor ventricular function, no electrophysiological substrate, or multimorphological tachycardia. Heart transplantation has to be considered especially in young patients in whom progression of the underlying disease can be anticipated. Bridging by AICD is possible when transplantation is not immediately available or recommendable.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Sano, K. Ishino, M. Kawada, S. Kasahara, T. Kohmoto, M. Takeuchi, and S.-i. Ohtsuki
Total right ventricular exclusion procedure: An operation for isolated congestive right ventricular failure
J. Thorac. Cardiovasc. Surg., April 1, 2002; 123(4): 640 - 647.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J P Bourke, A Loaiza, G Parry, C Hilton, S Furniss, J Dark, and J Forty
Role of orthotopic heart transplantation in the management of patients with recurrent ventricular tachyarrhythmias following myocardial infarction
Heart, November 1, 1998; 80(5): 473 - 478.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.